The researchers’ goal was to determine whether occipital nerve stimulation could serve as an effective treatment for patients with medically intractable chronic cluster headache.
In 2019, 22.1 percent of U.S. adults with chronic pain reported using a prescription opioid in the previous three months.
Study authors conducted a meta-analysis of randomized controlled trials to study the effectiveness of psychotropic medications in children and adolescents with chronic pain.
Widespread pain, a common subtype of chronic pain, is associated with the subsequent risk for incident dementia, AD dementia, and stroke.
The phase 3 RALLY study is evaluating the efficacy and safety of TNX-102 SL in 514 adult patients with fibromyalgia.
Patients with CM and overlapping pain have worse pain-related physical function and psychosocial functioning than those with localized CM.
A Weill Cornell Medicine team analyzed Health Care Cost Institute database claims, with opioid prescription gaps ≥30 days considered long-term nonuse.
The researchers’ goal was to provide the initial evidence for the safety and efficacy of sublingual ketamine in patients with chronic nonmalignant pain.
The FDA has approved the Senza® Omnia spinal cord stimulation system for the treatment of chronic pain associated with PDN.
Researchers presented a study protocol for a trial evaluating the efficacy of 3 forms of virtual reality interventions for patients with highly prevalent chronic lower back pain.
